Eastwoods Consulting
Notes from the East Woods

musings on opportunities in the life science marketplace

      February 2010 
  
EC border

Greetings!

Flocking to a carcass is not for everyone.  Please have a read and feel free to let me know what you think. 

We would also like to extend a sincere thank you to all of our clients, colleagues, and friends that have helped us over the years as we celebrate the 5 year anniversary of our founding. Thanks and we look forward to the next 5.

Regards,

Paul Danis
Founder and Principal

 
Join Our Mailing List!
This Month's Features
- Carcasses and Niches
- Life Science Market Update
- About Us
Carcasses and Niches

XC Ski


I was cross country skiing last weekend, enjoying a crisp winter afternoon, when I came across a flock of birds picking over a carcass.  Rather than gather seeds peacefully from the millions of pine cones in the forest, these creatures chose to battle each other for a few scraps of coyote (or whatever the brown-furred thing used to be.)  It reminded me of many life science markets where companies flock to certain segments all hoping to get a big chunk.  What they often get are just a few nibbles.  The key thing here is choosing where to get your nourishment (sales) - do you go where everyone is and try to battle it out, or do you find a cache that you can have all to yourself.

 

Many of the companies I work with are faced with this common dilemma - own a niche or battle for a piece of the big pie.  With many new technologies and products coming to the market, this question must be answered quite regularly, and the most common answer is - 'both.'  It is human nature to go after any potential business for your products or services.  But to really succeed you usually need to let go of a few areas to put your efforts where you will be most efficient.

 

So what can you do to get focused?  First you need to agree that a focused effort will provide a better pathway toward growth and increased profits.  If the birds had flown all over the place whenever there was a hint of food, they would have exhausted their energy and turned into fuzzy ice cubes.  They have to carefully choose the nutritional sources that give the most energy and are readily accessible.  In essence they figured out the return on their investment in their tiny little heads.

 

Companies do this as well, based on wonderful rosy forecasts.  The biggest challenge, though, comes in honestly assessing what it would take to capture that amount of business.  Here are some of the things that must be considered when deciding where to sell your products.

  • Channels - Can you get to the people who have the problem your product solves.  And can you do what is necessary to help them be successful with it.
  • Value - Your product or service must not only provide a good ROI to you, but more importantly for your customers.  If you were in them, would you buy it?

  • Competition - Is this segment ruled by a couple big guys or is it a free-for-all with everyone getting a small piece of the carcass.

  • Cash - Most importantly,  do you need to generate some fast cash or can you afford to nurture and develop a new area of the market

  • Barriers - Do you have to cross mountains to get to the tasty feast or is it next door.  This is where folks tend to underestimate what it takes for people to adopt their product. 

So when it is time to choose your source of nutrition be sure to consider carefully what will best help you grow.  Simply going wherever there is sustenance may not be the wisest approach.  Take a careful look at the options and decide what will nourish you the best.  You don't what to chase every opportunity and run out of energy before your reach your next meal.



Life Science Market Update

Index

January Value

Change 12mo.

12 mo. High

12 mo. Low

EC BioTools

631

45%

639

411

EC BigPharma

789

16%

796

587

EC Biotech

582

16%

582

446


Biotech is the star of this month, rising to a 12 month high while the Tools and Pharma were off slightly.  Illimina outshone its brethren with a 20% appreciation for the month on news of its new machine for $10,000 DNA sequencing as well as strong revenue.    Otherwise declines led advances 4 to 1 for Tools while Pharma was at 2-1.  Biotech's strength was evident as advances led declines 2 to 1.  


EC BioIndex January 2010

EC BioIndex


---------------------
Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
  • EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR, CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL, TMO, VARI, WAT
  • EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, LUN, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, KG, ROG.VX
  • EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD, BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR
  • Prices are taken at the close of each month.  YTD is the year to date change taken from the end of December, 2008.
EC Border
 
About Eastwoods Consulting
Eastwoods Consulting

Translating Innovations into Profits for the Life Science Industrysm

Eastwoods Consulting helps life science companies grow their businesses.  Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
 


Copyright © 2010, Eastwoods Consulting. This publication may be freely redistributed in full or in part as long as full attribution including our contact information and web address, are included.  Eastwoods is a registered servicemark of Eastwoods Consultng.